President and CEO
Dr. A. William Kedia is a board certified, renowned physician and entrepreneur based in Cleveland, OH. When the COVID-19 pandemic began, Dr. Kedia had a front row seat witnessing the suffering of patients & the havoc created in the healthcare system and our economy. With the misery imposed by the virus on all of us, Dr. Kedia explored ways to help the global community using innovative technologies.
As CEO and co-founder of MedAir Labs, he has set a mission for his team to develop meaningful solutions in areas of diagnostics and therapeutics to assist in the global health crisis. With his extensive business reach, he has assembled a team of global professionals with experience in areas of public health, medicine, supply chain, manufacturing and commercialization.
As part of this mission, MedAir Labs has invested significant resources to develop SERENIO, a revolutionary patented technology that neutralizes airborne and surface coronaviruses including COVID-19; Antiviral PPE solutions and advanced Triple Antigen Testing kits that are in clinical trials. His leadership has allowed MedAir Labs to partner with a global biotech firm for vaccine development and production; currently in stage 3 clinical trials in India.
With corporate headquarters in Cleveland OH, MedAir Labs is at the forefront with products & solutions to safely reopen the global economy.
APAC Region
APAC Region
APAC Region
We have strong partnerships with manufacturing presence in China, India and Vietnam. We have sales and operations in all other countries in the region.
Europe
APAC Region
APAC Region
Europe is a leading destination for our products and services. We operate in all of European Union and Britain.
Africa
APAC Region
Africa
Our emerging markets are in Africa and we are aggressive about our investments and expansion in this region.